• $3.99

Publisher Description

A new biotechnology firm, Pharma Technologies, has developed a competing method for the treatment of erectile dysfunction which promises significant advantages over Pfizer's blockbuster drug, Viagra. With deep-pocketed pharmaceutical companies also pursuing product development efforts, the president of Pharma Technologies is charged with deciding how to leverage his company's superior proprietary technology into a viable product before the window of opportunity closes. Students can explore the trade-offs is pursuing internal versus external development of new technology, the strategic implications of in-licensing and out-licensing, and the criteria used in identifying potential alliance partners to expedite the commercialization of new technology.

GENRE
Business & Personal Finance
RELEASED
2004
September 20
LANGUAGE
EN
English
LENGTH
11
Pages
PUBLISHER
Richard Ivey School of Business Foundation
SELLER
Ivey Business School Foundation
SIZE
308.6
KB

More Books by Charlene L. Nicholls-Nixon